GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Obio Technology (shanghai) Corp Ltd (SHSE:688238) » Definitions » Issuance of Debt

Obio Technology (shanghai) (SHSE:688238) Issuance of Debt : ¥210.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Obio Technology (shanghai) Issuance of Debt?

Obio Technology (shanghai)'s Issuance of Debt for the three months ended in Mar. 2025 was ¥180.0 Mil.

Obio Technology (shanghai)'s Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 was ¥210.0 Mil.

Obio Technology (shanghai) Issuance of Debt Historical Data

The historical data trend for Obio Technology (shanghai)'s Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Obio Technology (shanghai) Issuance of Debt Chart

Obio Technology (shanghai) Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.00 101.30 49.34 111.00 90.00

Obio Technology (shanghai) Quarterly Data
Jun19 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.00 - 30.00 - 180.00

Obio Technology (shanghai) Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥210.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Obio Technology (shanghai) Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Obio Technology (shanghai)'s Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Obio Technology (shanghai) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Obio Technology (shanghai) Corp Ltd (SHSE:688238) » Definitions » Issuance of Debt
Comparable Companies
SZSE:300942 SZSE:300381 SZSE:300653 SZSE:300147 SZSE:300583 SHSE:688399 SZSE:301230 SHSE:603896 SZSE:300858 SHSE:688202 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Lane 908, Ziping Road, Building 19, International Medical Park, Pudong New Area, Shanghai, CHN, 201321
Website
https://www.obiosh.com
Obio Technology (shanghai) Corp Ltd is a biotechnology company focusing on the field of gene therapy, focusing on the development of gene therapy vectors, gene function research, drug targets and efficacy for the basic research of gene therapy Research and other CRO services, and provide CDMO services such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs.
Executives
You Qing Rui Directors, senior managers
Pan Jun Yi Director
Yang Jia Li Core technical personnel

Obio Technology (shanghai) Headlines

No Headlines